{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:43:44Z","timestamp":1778881424469,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Department of Obstetrics Gynaecology and Newborn Health, University of Melbourne"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-33220-2","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:03:21Z","timestamp":1768406601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating valaciclovir, letermovir, and maribavir safety in first-trimester human placental development"],"prefix":"10.1038","volume":"16","author":[{"given":"Ishara","family":"Atukorala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"de Alwis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Beard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swetha","family":"Raghavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie J.","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Hui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"issue":"8","key":"33220_CR1","doi-asserted-by":"publisher","first-page":"e2120736","DOI":"10.1001\/jamanetworkopen.2021.20736","volume":"4","author":"P Ssentongo","year":"2021","unstructured":"Ssentongo, P. et al. Congenital cytomegalovirus infection burden and epidemiologic risk factors in countries with universal screening: A systematic review and Meta-analysis. JAMA Netw. Open. 4 (8), e2120736 (2021).","journal-title":"JAMA Netw. Open."},{"issue":"6","key":"33220_CR2","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.ajog.2020.05.038","volume":"223","author":"C Chatzakis","year":"2020","unstructured":"Chatzakis, C. et al. Timing of primary maternal cytomegalovirus infection and rates of vertical transmission and fetal consequences. Am. J. Obstet. Gynecol. 223 (6), 870\u201383e11 (2020).","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"10","key":"33220_CR3","doi-asserted-by":"publisher","first-page":"101101","DOI":"10.1016\/j.ajogmf.2023.101101","volume":"5","author":"L Zammarchi","year":"2023","unstructured":"Zammarchi, L. et al. Treatment with valacyclovir during pregnancy for prevention of congenital cytomegalovirus infection: a real-life multicenter Italian observational study. Am. J. Obstet. Gynecol. MFM. 5 (10), 101101 (2023).","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"issue":"4","key":"33220_CR4","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/uog.23685","volume":"58","author":"V Faure-Bardon","year":"2021","unstructured":"Faure-Bardon, V., Fourgeaud, J., Stirnemann, J., Leruez-Ville, M. & Ville, Y. Secondary prevention of congenital cytomegalovirus infection with valacyclovir following maternal primary infection in early pregnancy. Ultrasound Obstet. Gynecol. 58 (4), 576\u2013581 (2021).","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"2","key":"33220_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ajog.2023.07.022","volume":"230","author":"C Chatzakis","year":"2024","unstructured":"Chatzakis, C. et al. The effect of valacyclovir on secondary prevention of congenital cytomegalovirus infection, following primary maternal infection acquired periconceptionally or in the first trimester of pregnancy. An individual patient data meta-analysis. Am. J. Obstet. Gynecol. 230 (2), 109 \u2013\u200917.e2 (2024).","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"10253","key":"33220_CR6","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0140-6736(20)31868-7","volume":"396","author":"K Shahar-Nissan","year":"2020","unstructured":"Shahar-Nissan, K. et al. Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial. Lancet 396 (10253), 779\u2013785 (2020).","journal-title":"Lancet"},{"key":"33220_CR7","doi-asserted-by":"crossref","unstructured":"Leruez-Ville, M. et al. Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI). Lancet Reg. Health  Eur. 40, 100892 (2024).","DOI":"10.1016\/j.lanepe.2024.100892"},{"issue":"3","key":"33220_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ajog.2020.02.018","volume":"223","author":"M Leruez-Ville","year":"2020","unstructured":"Leruez-Ville, M., Foulon, I., Pass, R. & Ville, Y. Cytomegalovirus infection during pregnancy: state of the science. Am. J. Obstet. Gynecol. 223 (3), 330\u2013349 (2020).","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"9","key":"33220_CR9","doi-asserted-by":"publisher","first-page":"e0240521","DOI":"10.1128\/aac.02405-21","volume":"66","author":"V Halpern-Cohen","year":"2022","unstructured":"Halpern-Cohen, V. & Blumberg, E. A. New perspectives on antimicrobial agents: maribavir. Antimicrob. Agents Chemother. 66 (9), e0240521 (2022).","journal-title":"Antimicrob. Agents Chemother."},{"key":"33220_CR10","doi-asserted-by":"publisher","first-page":"1385762","DOI":"10.3389\/fimmu.2024.1385762","volume":"15","author":"S Khorami-Sarvestani","year":"2024","unstructured":"Khorami-Sarvestani, S. et al. Placenta: an old organ with new functions. Front. Immunol. 15, 1385762 (2024).","journal-title":"Front. Immunol."},{"issue":"5","key":"33220_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.thromres.2004.06.038","volume":"114","author":"NM Gude","year":"2004","unstructured":"Gude, N. M., Roberts, C. T., Kalionis, B. & King, R. G. Growth and function of the normal human placenta. Thromb. Res. 114 (5), 397\u2013407 (2004).","journal-title":"Thromb. Res."},{"issue":"3","key":"33220_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/aji.12436","volume":"75","author":"SK Gupta","year":"2016","unstructured":"Gupta, S. K., Malhotra, S. S., Malik, A., Verma, S. & Chaudhary, P. Cell signaling pathways involved during invasion and syncytialization of trophoblast cells. Am. J. Reprod. Immunol. 75 (3), 361\u2013371 (2016).","journal-title":"Am. J. Reprod. Immunol."},{"issue":"6","key":"33220_CR13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s00018-022-04285-3","volume":"79","author":"B Dietrich","year":"2022","unstructured":"Dietrich, B., Haider, S., Meinhardt, G., Pollheimer, J. & Kn\u00f6fler, M. WNT and NOTCH signaling in human trophoblast development and differentiation. Cell. Mol. Life Sci. 79 (6), 292 (2022).","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"33220_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12958-022-00923-4","volume":"20","author":"E Chronopoulou","year":"2022","unstructured":"Chronopoulou, E. et al. Wnt4, Wnt6 and \u03b2-catenin expression in human placental tissue - is there a link with first trimester miscarriage? Results from a pilot study. Reprod. Biol. Endocrinol. 20 (1), 51 (2022).","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"5","key":"33220_CR15","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1071\/RD14079","volume":"28","author":"SB Nayeem","year":"2016","unstructured":"Nayeem, S. B., Arfuso, F., Dharmarajan, A. & Keelan, J. A. Role of Wnt signalling in early pregnancy. Reprod. Fertil. Dev. 28 (5), 525\u2013544 (2016).","journal-title":"Reprod. Fertil. Dev."},{"issue":"4","key":"33220_CR16","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.2353\/ajpath.2006.050686","volume":"168","author":"J Pollheimer","year":"2006","unstructured":"Pollheimer, J. et al. Activation of the canonical wingless\/T-cell factor signaling pathway promotes invasive differentiation of human trophoblast. Am. J. Pathol. 168 (4), 1134\u20131147 (2006).","journal-title":"Am. J. Pathol."},{"key":"33220_CR17","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1016\/j.placenta.2006.11.003","volume":"28","author":"S Sonderegger","year":"2007","unstructured":"Sonderegger, S., Husslein, H., Leisser, C. & Kn\u00f6fler, M. Complex expression pattern of Wnt ligands and frizzled receptors in human placenta and its trophoblast subtypes. Placenta 28, S97\u2013102 (2007). Suppl A(Suppl A).","journal-title":"Placenta"},{"key":"33220_CR18","doi-asserted-by":"publisher","first-page":"251686572110642","DOI":"10.1177\/25168657211064232","volume":"15","author":"R Guo","year":"2022","unstructured":"Guo, R. & Xing, Q. S. Roles of Wnt signaling pathway and ROR2 receptor in embryonic development: an update review Article. Epigenet Insights. 15, 25168657211064232 (2022).","journal-title":"Epigenet Insights"},{"issue":"3","key":"33220_CR19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000147847","volume":"156","author":"L Vi\u0107ovac","year":"1996","unstructured":"Vi\u0107ovac, L. & Aplin, J. D. Epithelial-mesenchymal transition during trophoblast differentiation. Acta Anat. (Basel). 156 (3), 202\u2013216 (1996).","journal-title":"Acta Anat. (Basel)"},{"issue":"1","key":"33220_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2013.02.037","volume":"341","author":"Y Nakaya","year":"2013","unstructured":"Nakaya, Y. & Sheng, G. EMT in developmental morphogenesis. Cancer Lett. 341 (1), 9\u201315 (2013).","journal-title":"Cancer Lett."},{"issue":"3","key":"33220_CR21","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1080\/19336918.2016.1170258","volume":"10","author":"JED Pollheimer","year":"2016","unstructured":"Pollheimer, J. E. D., Yong, J., Kokkinos, H. E., Kalionis, M. I. & Kn\u00f6fler, B. Epithelial-mesenchymal transition during extravillous trophoblast differentiation. Cell. Adh Migr. 10 (3), 310\u2013321 (2016).","journal-title":"Cell. Adh Migr."},{"issue":"9","key":"33220_CR22","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.placenta.2010.06.017","volume":"31","author":"MI Kokkinos","year":"2010","unstructured":"Kokkinos, M. I., Murthi, P., Wafai, R., Thompson, E. W. & Newgreen, D. F. Cadherins in the human placenta \u2013 epithelial\u2013mesenchymal transition (EMT) and placental development. Placenta 31 (9), 747\u2013755 (2010).","journal-title":"Placenta"},{"issue":"1","key":"33220_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/hr.2016.97","volume":"40","author":"L Du","year":"2017","unstructured":"Du, L. et al. Mesenchymal-to-epithelial transition in the placental tissues of patients with preeclampsia. Hypertens. Res. 40 (1), 67\u201372 (2017).","journal-title":"Hypertens. Res."},{"issue":"7","key":"33220_CR24","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","volume":"124","author":"S Rana","year":"2019","unstructured":"Rana, S., Lemoine, E., Granger, J. P. & Karumanchi, S. A. Preeclampsia: Pathophysiology, Challenges, and perspectives. Circ. Res. 124 (7), 1094\u20131112 (2019).","journal-title":"Circ. Res."},{"issue":"4","key":"33220_CR25","doi-asserted-by":"publisher","first-page":"462e1-e10","DOI":"10.1016\/j.ajog.2016.04.003","volume":"215","author":"M. Leruez-Ville","year":"2016","unstructured":"Leruez-Ville, M. et al. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study. Am. J. Obstet. Gynecol. 215 (4), 462e1-e10 (2016).","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"33220_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/bdra.20013","volume":"70","author":"KM Stone","year":"2004","unstructured":"Stone, K. M. et al. Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the international acyclovir pregnancy registry, 1984\u20131999. Birth Defects Res. Clin. Mol. Teratol. 70 (4), 201\u2013207 (2004).","journal-title":"Birth Defects Res. Clin. Mol. Teratol"},{"issue":"2","key":"33220_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0166-3542(00)00139-X","volume":"49","author":"P Wutzler","year":"2001","unstructured":"Wutzler, P. & Thust, R. Genetic risks of antiviral nucleoside analogues\u2013a survey. Antiviral Res. 49 (2), 55\u201374 (2001).","journal-title":"Antiviral Res."},{"issue":"4","key":"33220_CR28","doi-asserted-by":"publisher","first-page":"e0232140","DOI":"10.1371\/journal.pone.0232140","volume":"15","author":"V Faure Bardon","year":"2020","unstructured":"Faure Bardon, V. et al. Placental transfer of letermovir & maribavir in the ex vivo human cotyledon perfusion model. New perspectives for in utero treatment of congenital cytomegalovirus infection. PLoS One. 15 (4), e0232140 (2020).","journal-title":"PLoS One"},{"issue":"1","key":"33220_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.01627-20","volume":"65","author":"S. T. Hamilton","year":"2020","unstructured":"Hamilton, S. T., Marschall, M. & Rawlinson, W. D. Investigational antiviral therapy models for the prevention and treatment of congenital cytomegalovirus infection during pregnancy. Antimicrob. Agents Chemother. 65 (1), 10\u2013128 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"33220_CR30","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3390\/antiox11091677","volume":"11","author":"N de Alwis","year":"2022","unstructured":"de Alwis, N. et al. Placental OLAH levels are altered in fetal growth Restriction, preeclampsia and models of placental dysfunction. Antioxidants 11 (9), 1677 (2022).","journal-title":"Antioxidants"},{"issue":"4","key":"33220_CR31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.preghy.2014.09.003","volume":"4","author":"TJ Kaitu\u2019u-Lino","year":"2014","unstructured":"Kaitu\u2019u-Lino, T. J. et al. Characterization of protocols for primary trophoblast purification, optimized for functional investigation of sFlt-1 and soluble endoglin. Pregnancy Hypertens. 4 (4), 287\u2013295 (2014).","journal-title":"Pregnancy Hypertens."},{"key":"33220_CR32","doi-asserted-by":"publisher","first-page":"103985","DOI":"10.1016\/j.jri.2023.103985","volume":"158","author":"B Huppertz","year":"2023","unstructured":"Huppertz, B. Placental physioxia is based on Spatial and Temporal variations of placental oxygenation throughout pregnancy. J. Reprod. Immunol. 158, 103985 (2023).","journal-title":"J. Reprod. Immunol."},{"issue":"6","key":"33220_CR33","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/jac\/dkh244","volume":"53","author":"C MacDougall","year":"2004","unstructured":"MacDougall, C. & Guglielmo, B. J. Pharmacokinetics of valaciclovir. J. Antimicrob. Chemother. 53 (6), 899\u2013901 (2004).","journal-title":"J. Antimicrob. Chemother."},{"key":"33220_CR34","unstructured":"Administration, U. S. F. D. PREVYMIS (letermovir) Tablets and PREVYMIS (letermovir) Injection 2017 [updated 11\/08\/2017. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2017\/209939Orig1s000,209940Orig1s000TOC.cfm"},{"issue":"11","key":"33220_CR35","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1093\/bioinformatics\/btp184","volume":"25","author":"S Preibisch","year":"2009","unstructured":"Preibisch, S., Saalfeld, S. & Tomancak, P. Globally optimal Stitching of tiled 3D microscopic image acquisitions. Bioinformatics 25 (11), 1463\u20131465 (2009).","journal-title":"Bioinformatics"},{"issue":"8","key":"33220_CR36","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1038\/emm.2014.44","volume":"46","author":"Y-S Kim","year":"2014","unstructured":"Kim, Y-S., Yi, B-R., Kim, N-H. & Choi, K-C. Role of the epithelial\u2013mesenchymal transition and its effects on embryonic stem cells. Exp. Mol. Med. 46 (8), e108 (2014).","journal-title":"Exp. Mol. Med."},{"issue":"8","key":"33220_CR37","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1001\/jama.2010.1206","volume":"304","author":"B Pasternak","year":"2010","unstructured":"Pasternak, B. & Hviid, A. Use of Acyclovir, Valacyclovir, and Famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA 304 (8), 859\u2013866 (2010).","journal-title":"JAMA"},{"issue":"11","key":"33220_CR38","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.3390\/v15112142","volume":"15","author":"M. Rybak-Krzyszkowska","year":"2023","unstructured":"Rybak-Krzyszkowska, M. et al. Cytomegalovirus infection in pregnancy prevention and treatment options: A systematic review and Meta-Analysis. Viruses 15 (11), 2142 (2023).","journal-title":"Viruses"},{"issue":"12","key":"33220_CR39","doi-asserted-by":"publisher","first-page":"e52899","DOI":"10.1371\/journal.pone.0052899","volume":"7","author":"ST Hamilton","year":"2012","unstructured":"Hamilton, S. T. et al. Human cytomegalovirus-induces cytokine changes in the placenta with implications for adverse pregnancy outcomes. PLoS One. 7 (12), e52899 (2012).","journal-title":"PLoS One"},{"issue":"9","key":"33220_CR40","doi-asserted-by":"publisher","first-page":"100808","DOI":"10.1016\/j.modpat.2025.100808","volume":"38","author":"EM Pena-Burgos","year":"2025","unstructured":"Pena-Burgos, E. M. et al. The spectrum of placental findings of First-Trimester cytomegalovirus infection related to the presence of symptoms in the newborns and stillbirths. Mod. Pathol. 38 (9), 100808 (2025).","journal-title":"Mod. Pathol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33220-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33220-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33220-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T01:03:54Z","timestamp":1769475834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33220-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["33220"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-33220-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3357"}}